Kimberly-Clark Corporation (NASDAQ:KMB – Get Free Report) insider Katy Chen sold 1,596 shares of the business’s stock in a transaction on Monday, May 4th. The shares were sold at an average price of $95.34, for a total transaction of $152,162.64. Following the transaction, the insider directly owned 8,362 shares of the company’s stock, valued at approximately $797,233.08. This trade represents a 16.03% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Katy Chen also recently made the following trade(s):
- On Thursday, April 30th, Katy Chen sold 1,405 shares of Kimberly-Clark stock. The shares were sold at an average price of $96.95, for a total transaction of $136,214.75.
Kimberly-Clark Trading Up 2.0%
Kimberly-Clark stock opened at $99.19 on Thursday. Kimberly-Clark Corporation has a 52-week low of $92.42 and a 52-week high of $144.30. The company has a quick ratio of 0.55, a current ratio of 0.77 and a debt-to-equity ratio of 3.38. The firm has a market capitalization of $32.93 billion, a price-to-earnings ratio of 15.57, a PEG ratio of 4.65 and a beta of 0.29. The firm has a 50-day moving average price of $99.82 and a two-hundred day moving average price of $103.15.
Kimberly-Clark News Roundup
Here are the key news stories impacting Kimberly-Clark this week:
- Positive Sentiment: April-quarter results showed EPS of $1.97 and revenue of $4.16B, both topping consensus and reflecting 2.7% revenue growth—evidence of resilient core demand that underpins today’s buying interest.
- Positive Sentiment: The EU is expected to grant unconditional antitrust approval for Kimberly‑Clark’s $3.4bn JV with Suzano, removing a major regulatory overhang and clearing the way for the transaction to close. EU approval reportArticle
- Neutral Sentiment: Huggies launched a new “Natural Born Fighters” marketing campaign to support brand equity in baby care—positive for long‑term brand health but unlikely to move near‑term fundamentals materially. Huggies campaignArticle
- Neutral Sentiment: Company participated in the Barclays conference (transcript available), offering incremental investor visibility into strategy and outlook—useful context but no headline guidance change. Conference transcriptArticle
- Negative Sentiment: Insider selling and finance leadership turnover are weighing on sentiment: VP Andrew Scribner sold 4,095 shares (filed with the SEC) and is reported to be leaving to become CF Industries’ CFO—raising short‑term governance and continuity questions. Scribner SEC filingSEC filing Scribner CF IndustriesArticle
- Negative Sentiment: Other insiders (e.g., Katy Chen) sold shares recently—some sales were tax‑related, but clustered insider dispositions can still create short‑term pressure. Insider salesArticle
- Negative Sentiment: Analyst coverage is largely neutral/hold with some downward target adjustments, leaving limited near‑term upside from street revisions absent stronger results or guidance. Analyst consensusArticle
Analysts Set New Price Targets
A number of equities analysts recently issued reports on KMB shares. UBS Group increased their target price on shares of Kimberly-Clark from $105.00 to $106.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. TD Cowen reduced their price target on shares of Kimberly-Clark from $112.00 to $105.00 and set a “hold” rating for the company in a research note on Thursday, January 8th. Wells Fargo & Company lowered their price objective on shares of Kimberly-Clark from $110.00 to $100.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 8th. Citigroup dropped their target price on Kimberly-Clark from $95.00 to $90.00 and set a “sell” rating on the stock in a report on Wednesday, January 14th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on Kimberly-Clark from $110.00 to $109.00 and set a “hold” rating for the company in a research note on Monday, March 30th. Four analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $114.93.
View Our Latest Report on Kimberly-Clark
Institutional Investors Weigh In On Kimberly-Clark
A number of large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in shares of Kimberly-Clark by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 40,846,734 shares of the company’s stock worth $4,121,027,000 after buying an additional 315,981 shares during the period. State Street Corp raised its holdings in Kimberly-Clark by 1.4% in the 4th quarter. State Street Corp now owns 21,125,118 shares of the company’s stock worth $2,157,746,000 after acquiring an additional 294,228 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Kimberly-Clark by 2.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 11,917,154 shares of the company’s stock worth $1,202,322,000 after acquiring an additional 299,382 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Kimberly-Clark by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 8,322,198 shares of the company’s stock valued at $836,216,000 after acquiring an additional 65,619 shares during the period. Finally, Massachusetts Financial Services Co. MA grew its position in shares of Kimberly-Clark by 50.4% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 7,839,572 shares of the company’s stock valued at $790,934,000 after purchasing an additional 2,628,206 shares during the last quarter. Institutional investors own 76.29% of the company’s stock.
About Kimberly-Clark
Kimberly-Clark Corporation is a U.S.-based multinational manufacturer of personal care and consumer tissue products. The company develops, produces and markets a range of consumer brands and professional products, including facial and bathroom tissues, disposable diapers and training pants, feminine care, incontinence products and workplace hygiene solutions. Known for consumer-facing names such as Kleenex, Huggies, Kotex, Cottonelle and Scott, as well as professional offerings under Kimberly-Clark Professional and KleenGuard, the company supplies goods to retail, healthcare and institutional customers.
Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark has expanded from its 19th-century paper-making roots into a global household and workplace products company.
See Also
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.
